BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/17/2022 3:19:26 AM | Browse: 240 | Download: 817
Publication Name World Journal of Clinical Cases
Manuscript ID 74609
Country/Territory China
Received
2021-12-29 14:28
Peer-Review Started
2021-12-29 14:30
To Make the First Decision
Return for Revision
2022-01-25 06:22
Revised
2022-02-14 14:26
Second Decision
2022-04-29 03:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-04-30 07:37
Articles in Press
2022-04-30 07:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-04-24 23:18
Typeset the Manuscript
2022-06-01 13:43
Publish the Manuscript Online
2022-06-17 03:19
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Meta-Analysis
Article Title Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Hua-Hua Yang, Yi Huang, Xu-Chun Zhou and Ruo-Nan Wang
ORCID
Author(s) ORCID Number
Hua-Hua Yang http://orcid.org/0000-0002-0065-2741
Yi Huang http://orcid.org/0000-0001-8049-1900
Xu-Chun Zhou http://orcid.org/0000-0002-5128-3149
Ruo-Nan Wang http://orcid.org/0000-0003-2049-6827
Funding Agency and Grant Number
Corresponding Author Xu-Chun Zhou, MD, Professor, Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China. chqxchzh@163.com
Key Words Crohn disease; Adalimumab; Infliximab; Clinical efficacy; Adverse effects; Meta-analysis
Core Tip Differences in immunogenicity and route of administration among adalimumab (ADA) and infliximab (IFX) allow for potential variability in therapeutic properties and efficacy. However, clear recommendations have been limited due to a lack of head-to-head comparison. We conducted a meta-analysis to synthesize current results and assessed the efficacy and safety between ADA and IFX. The result showed that both have similar clinical benefits for anti-tumor necrosis factor-alpha naive or non-naive Crohn’s disease patients. Overall adverse events rate is higher in patients in the IFX group. ADA and IFX can be chosen on a possible history of adverse events and patients’ compliance.
Publish Date 2022-06-17 03:19
Citation Yang HH, Huang Y, Zhou XC, Wang RN. Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis. World J Clin Cases 2022; 10(18): 6091-6104
URL https://www.wjgnet.com/2307-8960/full/v10/i18/6091.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i18.6091
Full Article (PDF) WJCC-10-6091.pdf
Full Article (Word) WJCC-10-6091.docx
PRISMA 2009 Checklist 74609-PRISMA-2009-Checklist-revision.pdf
Manuscript File 74609_Auto_Edited-JRF-Filipodia CL.docx
Answering Reviewers 74609-Answering reviewers.pdf
Audio Core Tip 74609-Audio core tip.mp3
Biostatistics Review Certificate 74609-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 74609-Conflict-of-interest statement.pdf
Copyright License Agreement 74609-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 74609-Language certificate.pdf
Supplementary Material 74609-Supplementary material.pdf
Peer-review Report 74609-Peer-review(s).pdf
Scientific Misconduct Check 74609-Bing-Fan JR-2.png
Scientific Editor Work List 74609-Scientific editor work list.pdf